Form 8-K - Current report:
SEC Accession No. 0001555280-24-000197
Filing Date
2024-04-01
Accepted
2024-04-01 16:34:52
Documents
15
Period of Report
2024-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20240401.htm   iXBRL 8-K 30471
2 EX-99.1 exhibit991newdirector.htm EX-99.1 13017
6 image_0.jpg GRAPHIC 40382
  Complete submission text file 0001555280-24-000197.txt   229806

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20240401.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20240401_lab.xml EX-101.LAB 22783
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20240401_pre.xml EX-101.PRE 13109
18 EXTRACTED XBRL INSTANCE DOCUMENT zts-20240401_htm.xml XML 2695
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 24810007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)